Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction

Chimeric antigen receptor (CAR) T cell therapy represents a breakthrough in immunotherapy with the potential of ushering in a new era in cancer treatment. Remarkable therapeutic response and complete remission of this innovative management have been observed in patients with relapse/refractory acute...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Ruimin Hong, Yongxian Hu, He Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Subjects:	chimeric antigen receptor T cell relapse/refractory acute lymphoblastic leukemia biomarkers therapeutic response adverse events
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.627764/full